Clinical Study Data Request Registered Users, Please Login

Find by:

Study ID:
Medicine:
Phase:

A Phase 3, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, 52-Wk Study to Evaluate the Efficacy and Safety of Belimumab (HGS1006, LymphoStat-B™), a Fully Human Monoclonal Anti-BLyS Antibody, in Subjects With Systemic Lupus Erythematosus (SLE)
belimumab
HGS1006-C1057
NCT00424476
Systemic Lupus Erythematosus
Phase 3
 
This study was not originally sponsored by GSK. The results summary and publications are available on ClinicalTrials.gov: http://clinicaltrials.gov/show/NCT00424476. GSK reference study ID: 110752. Raw data are included within the analysis-ready data for this study and are not provided separately
February 2014

Powered by ideaPoint, Inc.